» Articles » PMID: 20484489

Identification of Outer Membrane Porin F Protein of Yersinia Enterocolitica Recognized by Antithyrotopin Receptor Antibodies in Graves' Disease and Determination of Its Epitope Using Mass Spectrometry and Bioinformatics Tools

Overview
Specialty Endocrinology
Date 2010 May 21
PMID 20484489
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Context: In addition to genetic susceptibility, Yersinia enterocolitica (YE) infection played an important causative role in the pathogenesis of Graves' disease (GD) through molecular mimicry. However, the specific YE proteins and epitopes recognized by anti-TSH receptor (TSHR) autoantibodies (TRAb) have not been fully clarified, resulting in conflicting results from clinical research.

Objective: Our aim was to explore the roles of YE in the pathogenesis of GD and identify the YE proteins and epitopes that are similar to the TSHR and are recognized by TRAb.

Design: Assays of YE antibodies, TRAb, thyroglobulin antibodies, and thyroid microsomal antibodies as well as cross-absorption and two-way immunodiffusion were performed in patients with GD. Using mass spectrometry and the bioinformatics tools of protein structure modeling and epitope prediction, we identified the YE protein and its epitope, which was recognized by TRAb and was similar to TSHR.

Results: Our study demonstrated for the first time that the YE protein outer membrane porin F protein (ompF) shared cross-immunogenicity with a leucine-rich domain of TSHR. The epitope recognized by antihuman TSHR antibody is located within the ompF region of amino acids 190-197, and the polyantibody against ompF protein showed TSAb activity.

Conclusions: Our results suggest that YE ompF is involved in the production of TRAb and the pathogenesis of GD through molecular mimicry. These findings are potentially important for understanding the role molecular mimicry plays in the disturbance of immune tolerance and the induction of autoimmunity to the TSHR.

Citing Articles

The Gut Microbiota and Its Metabolites and Their Association with the Risk of Autoimmune Thyroid Disease: A Mendelian Randomization Study.

Zhang C, Teng W, Wang C, Shan Z Nutrients. 2024; 16(22).

PMID: 39599685 PMC: 11597551. DOI: 10.3390/nu16223898.


Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study.

Biscarini F, Masetti G, Muller I, Verhasselt H, Covelli D, Colucci G J Clin Endocrinol Metab. 2023; 108(8):2065-2077.

PMID: 36683389 PMC: 10807910. DOI: 10.1210/clinem/dgad030.


The relationships between the gut microbiota and its metabolites with thyroid diseases.

Jiang W, Lu G, Gao D, Lv Z, Li D Front Endocrinol (Lausanne). 2022; 13:943408.

PMID: 36060978 PMC: 9433865. DOI: 10.3389/fendo.2022.943408.


Gut Microbiome and the Role of Metabolites in the Study of Graves' Disease.

Liu H, Liu H, Liu C, Shang M, Wei T, Yin P Front Mol Biosci. 2022; 9:841223.

PMID: 35252357 PMC: 8889015. DOI: 10.3389/fmolb.2022.841223.


The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy.

Hou J, Tang Y, Chen Y, Chen D Front Cell Infect Microbiol. 2022; 11:739707.

PMID: 35004341 PMC: 8727912. DOI: 10.3389/fcimb.2021.739707.